ALK-Abelló A/S (4AJ0.F)
ALK-Abelló A/S, an allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
30.28+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+19.1%
The outlook
ALK-Abelló A/S currently reads as leaning bearish based on below its 50- & 200-day averages, 52% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Market cap
$6.71B
52-wk high
36.28
52-wk low
23.68
50-day avg
33.51
200-day avg
30.55
Trailing P/E
39.3